Measles ended years ago. Its fatal brain complication is still arriving in Manila

Subacute sclerosing panencephalitis is the complication that makes measles a disease worth preventing long after the rash has faded. It is a delayed, almost uniformly fatal neurodegenerative disorder caused by a persistent central nervous system infection with a defective, hypermutant measles virus, and it typically follows measles acquired in early childhood after a latency of years [s1].

That latency is the point of a new case series from the Philippines, published in Emerging Infectious Diseases. Because SSPE follows measles by years rather than weeks, the neurological consequences of an outbreak do not become visible until long after the outbreak itself has ended [s1].

What was reviewed

Researchers retrospectively reviewed the records of all 20 children admitted with a final diagnosis of SSPE to National Children's Hospital, a tertiary government paediatric hospital in Quezon City, between 1 January 2007 and 31 December 2022 [s1].

The median age was 6.2 years at hospital admission and 0.7 years at the reported measles illness — a gap that captures the disease's long incubation [s1]. For each child, the team estimated the calendar year of measles infection by subtracting the infection-to-admission interval from the admission year, then compared those estimates against the national record of measles outbreak activity [s1].

The Philippines had measles outbreaks in 2010–2011, 2013 and 2018–2019, the last of which was the largest in the World Health Organization Western Pacific Region during that period [s1]. Previously published SSPE data from the country ended in 2015, before any children infected in the 2018–2019 outbreak would be expected to show symptoms [s1].

The signal in the timing

Five of the 20 admissions — 25.0 percent — occurred in 2022 [s1]. Estimated infection dates placed four patients within the 2018–2019 outbreak, and all four were admitted during 2020–2022 [s1].

That is the pattern the authors were looking for: a cluster of SSPE admissions appearing two to four years after the country's largest recent measles outbreak, exactly the interval the disease's biology predicts. Given the multiyear latency, the authors warn that additional cases might emerge over the coming years [s1].

The outbreak that preceded them was large. Reported measles cases rose from 2,428 in 2017 to 48,525 in 2019 [s1]. Behind that surge was a collapse in coverage: first-dose measles-containing vaccine coverage fell from 92 percent in 2004–2007 to 80 percent in 2015–2016 and 64 percent in 2021 [s1].

What the series can and cannot show

This is a single-hospital review, not a national count, and it carries the limits the authors are candid about. The diagnosis rested on a clinical assessment by a paediatric neurologist together with qualitatively positive measles antibody in cerebrospinal fluid or serum; quantitative antibody titres, standardised electroencephalography and brain biopsy were unavailable, so the full Dyken diagnostic criteria could not be applied [s1].

Measles history came from parental recall recorded at admission, and a reported measles history could not be established in one quarter of the patients [s1]. The team excluded three children whose reported measles-to-admission interval was under a year, because such a short gap is atypical for SSPE and can instead reflect acute measles encephalitis or acute disseminated encephalomyelitis [s1].

None of that changes the direction of the finding. It means the 20 cases are a floor, not a ceiling — the children who reached one tertiary centre and received a confident diagnosis.

Why it matters beyond one hospital

Measles can cause severe disease, complications and death; among the complications WHO lists is encephalitis, an infection causing brain swelling and potential brain damage [s2]. Vaccination remains the most effective way to prevent measles and its spread, and the vaccine is safe [s2].

SSPE is the slow-motion version of that warning. It converts a coverage gap in one year into a cluster of fatal admissions half a decade later, which is why the authors' recommendation is unglamorous and specific: strengthened measles surveillance and sustained two-dose vaccination coverage [s1].

What to watch

Whether SSPE admissions in the Philippines continue to rise through the mid-2020s, as the cohort infected during the 2018–2019 outbreak moves further into the disease's latency window [s1]. The series establishes that the first of those cases has already arrived. It does not establish how many more are still to come.

This article is informational and is not medical advice.